Home > Insider Trading > Filing (0001104659-22-120873)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1811764	Point Biopharma Global Inc.	PNT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1009161	C Allan Silber	4850 West 78Th Street Indianapolis IN 46268	Executive Chairman	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-11-17	27,603	$6.00	4,246,208	No	4	P	Direct
Common Stock	Acquisiton	2022-11-18	22,397	$6.50	4,268,605	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	313,884	Indirect	By Spouse
Common Stock	538,087	Indirect	Trustee
Common Stock	4,035,655	Indirect	Silber Holdings, Inc.
Common Stock	71,744	Indirect	Anglian Holdings, LLC

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.20 to $6.60, inclusive. The Reporting Person undertakes to provide to POINT Biopharma Global Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Held in a trust for which the Reporting Person is the trustee.
Silber Holdings, Inc. is a corporation controlled by the Reporting Person.
Anglian Holdings, LLC is a limited liability company solely owned by the Reporting Person.